secwatch.observer — SEC 8-K summary
======================================

Issuer:     CASTLE BIOSCIENCES INC (CSTL)
CIK:        0001447362
Form:       8-K
Filed at:   2022-05-02T23:59:59+00:00
Accession:  0001447362-22-000074
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Castle Biosciences completes AltheaDx acquisition; issues 763,887 shares
------------------------------------------------------------------------

- $65M initial consideration: $32.5M cash and $32.5M in stock (763,887 shares).
- Up to $75M in milestone payments through Dec 31, 2024; 50% cash, 50% stock.
- Max shares issuable capped at 1,271,718; up to 507,831 more for milestones.
- Shares unregistered under Section 4(a)(2)/Reg D; resale registration due in 40 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1447362/000144736222000074/0001447362-22-000074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1447362/000144736222000074/cstl-20220426.htm
  HTML page:      https://secwatch.observer/filing/0001447362-22-000074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer